Pharmaceutical Executive-10-01-2022

Discerning Dealmaking: Caution Flag Still Raised in Biopharma M&A Race

October 11, 2022

Features

42

10

Big pharma’s finicky appetite for M&A comes as valuations of sellers soften. Though the pace of deals has picked up some, predicting just how long both sides will hold tight remains difficult.

Keeping it Simple

October 11, 2022

Executive Profile

42

10

Bristol Myers Squibb commercial head Chris Boerner believes a straightforward formula is the best formula in advancing innovation and developing talent in today’s complex healthcare climate—an approach he roots in authenticity and “not over engineering,” whether tackling business or culture.